AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Importance of R&D in Pharmaceutical CEOs
A Wall Street analyst report said pharmaceutical CEOs should stop investing in R&D and invest in non-farma assets. Merck had five-year earnings guidance, which only two of those five years had elapsed when I took over. "I felt very strongly that if Merck was going to be an R&D focus company, this was the moment of truth for us," he says.